Pl. Faries et al., Arm vein conduit is superior to composite prosthetic-autogenous grafts in lower extremity revascularization, J VASC SURG, 31(6), 2000, pp. 1119-1126
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Purpose: Various alternative conduits have been used for lower extremity re
vascularization when an adequate ipsilateral greater saphenous vein is abse
nt. This study compared the effectiveness of all-autogenous multisegment ar
m vein bypass grafts with that of composite grafts composed of combined pro
sthetic and autogenous conduits.
Methods: One hundred fifty-three lower extremity revascularization procedur
es per formed between 1990 and 1998 were followed up prospectively using a
computerized vascular registry. The grafts were composed of spliced arm vei
n segments with venovenostomy in 122 and of composite prosthetic-autogenous
conduit in 31. Arm vein conduit was prepared by means of intraoperative an
gioscopy for valve lysis and identification of luminal abnormalities in 47.
7% of cases.
Results: Bypass graft configurations were as follows: femoropopliteal (12 a
rm vein, 2 composite); femorotibial (75 arm vein, 23 composite); femoropeda
l (14 arm vein, 6 composite), and popliteo-tibial/pedal (21 arm vein, 0 com
posite). The indication for surgery was limb salvage in 98% and disabling d
audication in 2% of cases. The mean follow-up was 25.1 months (range, 1 mon
th to 7.9 years). Overall survival at 4 years was 51%. Overall patency and
limb salvage rates were as follows: primary patency, at 1 year-arm vein, 76
.9% +/- 4.8%; composite, 59.5% +/- 9.6% (P = .02); at 3 years-arm vein, 70.
0% +/- 8.0%; composite, 43.7% +/- 12.4% (P < .01); and at 5 years-arm vein,
53.8% +/- 8.7%; composite, 0%; secondary patency, at 1 year-arm vein, 77.5
% +/- 4.6%; composite, 59.8% +/- 9.5% (P = .02); at 3 years-arm vein, 70.7%
a 7.5%, composite, 44.9% +/- 13.1% (P < .01); at 5 years-arm vein, 57.7% /- 8.0%; composite, 0%; limb salvage, at 1 year-arm vein, 89.3% +/- 3.7%; c
omposite, 73.9% +/- 8.9% (P < .01); at 3 years-arm vein, 80.5% +/- 7.0%; co
mposite, 49.6% +/- 14.3% (P < .01); at 5 years-arm vein, 76.3% +/- 9.9%; co
mposite, 0%.
Conclusion: In this study, multisegment autogenous arm vein was used succes
sfully in a wide variety of lower extremity revascularization procedures an
d achieved good long-term patency and limb salvage rates, well in excess of
those achieved with composite prosthetic-autogenous grafts. The use of aut
ogenous conduit appears to offer superior results to composite conduit in l
ower extremity revascularization. The superior durability of arm vein makes
it one of the alternative conduits of choice when an adequate greater saph
enous vein is not available.